Core Viewpoint - Kanghua Medical (03689.HK) expects to report a profit of approximately RMB 32 million to RMB 33 million for the six months ending June 30, 2025, compared to a loss of about RMB 24.7 million for the same period ending June 30, 2024 [1] Financial Performance - The anticipated profit is primarily attributed to the sale of a 55% stake in Kangxin Hospital, which is expected to generate a gain of approximately RMB 19.5 million [1] - The financial performance of Kangxin Hospital has been removed from the group's consolidated financial statements following the sale, as it had been recording losses in previous years [1] Equity Accounting - The remaining 45% stake in Kangxin Hospital will be accounted for using the equity method, with an expected share of losses amounting to approximately RMB 18.4 million for the six months ending June 30, 2025 [1] - The losses from the remaining 55% stake will not be included in the group's financial performance for the mid-2025 period, resulting in a net positive impact on the group's financial results compared to the previous comprehensive accounting of Kangxin Hospital's losses [1]
康华医疗(03689.HK)盈喜：预计中期录得溢利3200万至3300万元